SEC Form 4 · accession 0001572426-15-000078
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George W Gunn
Director
Period of report
Jul 13, 2015
Accepted (ET)
Jul 14, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 13, 2015 | M | 900 | $0.125 | A | 900 | D | |
| Ordinary Shares | Jul 13, 2015 | M | 500 | $0.125 | A | 1,400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share Units | $0.125 | Jul 13, 2015 | M | 900 | D | Jun 30, 2015 | Jul 1, 2019 | Ordinary Shares | 900 | 0 | D |
| Restricted Share UnitsF1 | $0.125 | Jul 13, 2015 | M | 500 | D | Jun 30, 2015 | Jul 1, 2019 | Ordinary Shares | 500 | 5,500 | D |
Explanation of responses
- F1500 of the Restricted Share Units vested and became convertible on 6/30/15, and shall vest and become convertible with respect to an additional 500 shares on each of 9/30/15, 12/31/15, 3/31/16, 6/30/16, 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17 and 3/31/18 in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.